Academic Journal
Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes
Title: | Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes |
---|---|
Authors: | Afef Béjaoui, Issam Ben Salem, Nesrine Rokbeni, Yassine M’rabet, Mohamed Boussaid, Abdennacer Boulila |
Source: | Pharmaceutical Biology, Vol 55, Iss 1, Pp 906-911 (2017) |
Publisher Information: | Taylor & Francis Group, 2017. |
Publication Year: | 2017 |
Collection: | LCC:Therapeutics. Pharmacology |
Subject Terms: | hypericum species, hypericin, hyperforin, antioxidant, enzyme inhibitory, antimicrobial, Therapeutics. Pharmacology, RM1-950 |
More Details: | Context: Natural products are reported to have a wide spectrum of pharmacological properties such as antimicrobial, anti-inflammatory and anti-cholinesterase. The genus Hypericum (Hypericaceae) is a source of a variety of molecules with different biological activities, notably hypericin and various phenolics. Objectives: The goals of the present work were the determination of total phenolic and flavonoid content, hypericin and hyperforin concentration as well as the evaluation of biological of Hypericum humifusum L. (Hhu) and Hypericum perfoliatum L. (Hper). Materials and methods: The various extracts of aerial parts were powdered, and then extracted with methanol. Antibacterial activity was performed according to minimum inhibitory concentration (MIC) and minimum bactericidal (MBC) methods against four Gram-positive bacteria, four Gram-negative bacteria and yeast. Results: The results revealed that H. humifusum, bear the highest total phenolic and flavonoid content (48–113 mg GAE/g and 8–41 mg RE/g, respectively) as well as hypericin (60–90 mg/g) and hyperforin (8–30 mg/g) concentration. Both species showed significant antioxidant activity as revealed by DPPH, FRAP, ABTS, and metal chelating assays. H. humifusum exhibited a strong acetylcholinesterase (3.86–4.57 mg GALAEs/g), α-glucosidase (0.73–2.55 mmol ACEs/g) and α-amylase (3–8 mmol ACEs/g) inhibitory activity. The extract of H. humifusum exhibited strong antibacterial activity mainly against Staphylococcus epidermidis, Staphylococus aureus, and Enterococcus faecium (MIC values ranging from 200 to 250 μg/mL). The highest antifungal activity was showed for H. perfoliatum extract (MIC value = 250 μg/mL). Conclusion: The data suggest that H. humifusum could be used as valuable new natural agents with functional properties for pharmacology industries. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1388-0209 1744-5116 13880209 |
Relation: | https://doaj.org/toc/1388-0209; https://doaj.org/toc/1744-5116 |
DOI: | 10.1080/13880209.2016.1270973 |
Access URL: | https://doaj.org/article/6b16f7fb13a94bfdbd4017e6fc4825cb |
Accession Number: | edsdoj.6b16f7fb13a94bfdbd4017e6fc4825cb |
Database: | Directory of Open Access Journals |
Full text is not displayed to guests. | Login for full access. |
FullText | Links: – Type: pdflink Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwF5wgowxVShoVlO90pWa14PAAAA4jCB3wYJKoZIhvcNAQcGoIHRMIHOAgEAMIHIBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDCd8TK-_3ezMACSpYQIBEICBmhRALFx19F4lBotgxUb5QXhC3k8SrazJTeHp6AOhobOyhs3khFBsgx5deiuT3wPkm2Js-MR2TDJnoXXC8oHaAzI9esCAoBXh_qNHaH5QDrb8lXPPm0B7y9U9a644yEMTQsizo8Y9wXBLZIVvkx6TjBP31lp5oKVcsjbtUn6xZ4gEw3AoRfz8DWB1vEQ8yAmUTcidShJ8uwTqh0s= Text: Availability: 1 Value: <anid>AN0126815675;8fr01dec.17;2019Feb14.08:25;v2.2.500</anid> <title id="AN0126815675-1">Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum : inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes. </title> <p>Context: Natural products are reported to have a wide spectrum of pharmacological properties such as antimicrobial, anti-inflammatory and anti-cholinesterase. The genus Hypericum (Hypericaceae) is a source of a variety of molecules with different biological activities, notably hypericin and various phenolics. Objectives: The goals of the present work were the determination of total phenolic and flavonoid content, hypericin and hyperforin concentration as well as the evaluation of biological of Hypericum humifusum L. (Hhu) and Hypericum perfoliatum L. (Hper). Materials and methods: The various extracts of aerial parts were powdered, and then extracted with methanol. Antibacterial activity was performed according to minimum inhibitory concentration (MIC) and minimum bactericidal (MBC) methods against four Gram-positive bacteria, four Gram-negative bacteria and yeast. Results: The results revealed that H. humifusum, bear the highest total phenolic and flavonoid content (48–113 mg GAE/g and 8–41 mg RE/g, respectively) as well as hypericin (60–90 mg/g) and hyperforin (8–30 mg/g) concentration. Both species showed significant antioxidant activity as revealed by DPPH, FRAP, ABTS, and metal chelating assays. H. humifusum exhibited a strong acetylcholinesterase (3.86–4.57 mg GALAEs/g), α-glucosidase (0.73–2.55 mmol ACEs/g) and α-amylase (3–8 mmol ACEs/g) inhibitory activity. The extract of H. humifusum exhibited strong antibacterial activity mainly against Staphylococcus epidermidis, Staphylococus aureus, and Enterococcus faecium (MIC values ranging from 200 to 250 μg/mL). The highest antifungal activity was showed for H. perfoliatum extract (MIC value = 250 μg/mL). Conclusion: The data suggest that H. humifusum could be used as valuable new natural agents with functional properties for pharmacology industries.</p> <p>Keywords: Hypericum species; hypericin; hyperforin; antioxidant; enzyme inhibitory; antimicrobial</p> <hd id="AN0126815675-2">Introduction</hd> <p>The genus <emph>Hypericum</emph> L. (Hypericaceae) contains 484 species that have been classified into 36 taxonomic sections in all the continents except Antarctica. <emph>Hypericum</emph> species are perennial, herbaceous, or scrubby. There has been increasing interest in the genus <emph>Hypericum</emph>, because it is a source of a variety of molecules with different biological activities (Kizil et al. [<reflink idref="bib27" id="ref1">27</reflink>]), notably hypericin and various phenolics. The concentration of these compounds in plant tissues vary among plant parts, phonological stages and origin. These compounds exhibited a wide spectrum of pharmacological properties such as antimicrobial (Agostinis et al. [<reflink idref="bib1" id="ref2">1</reflink>]), anti-inflammatory, and anti-cholinesterase (Kamatou et al. [<reflink idref="bib26" id="ref3">26</reflink>]; Cardile et al. [<reflink idref="bib9" id="ref4">9</reflink>]), anticancer (Butterwerck et al. [<reflink idref="bib6" id="ref5">6</reflink>]), antidepressant (Jacobson et al. [<reflink idref="bib25" id="ref6">25</reflink>]), antiviral (Cakir et al. [<reflink idref="bib7" id="ref7">7</reflink>]), antioxidant (Ali et al. [<reflink idref="bib2" id="ref8">2</reflink>]), antifungal and antimalarial (Unal et al. [<reflink idref="bib46" id="ref9">46</reflink>]) activities. Benzopyran of xanthones and flovonoid derived from these compounds are known to have antimicrobial activity against various fungi and bacteria (Conforti et al. [<reflink idref="bib12" id="ref10">12</reflink>]).</p> <p>Tunisian flora contains eight <emph>Hypericum</emph> species; <emph>H. perforatum</emph> L., <emph>H. humifusum</emph> L., <emph>H</emph>. <emph>tomentosum</emph> L., <emph>H. perfoliatum</emph> L., <emph>H. triquetrifolium</emph> Turr., <emph>H. ericoides</emph> L., <emph>H. androsaemum</emph> L., and <emph>H. afrum</emph> Desf. (Pottier-Alapetite [<reflink idref="bib39" id="ref11">39</reflink>]).</p> <p> <emph>Hypericum humifusum</emph> L. is a short perennial and diploid species (Matzk et al. [<reflink idref="bib29" id="ref12">29</reflink>]) common in the Mediterranean area, and in western, and central Europe (Nogueira et al. [<reflink idref="bib35" id="ref13">35</reflink>]). It is an outcrosser, reproduces by seeds, and shows some capacity to reproduce vegetatively through sprouts. Leaves are simple and lanceolate. Flowers, grouped in a terminal corymb, are yellow, veined of red. However, it is widely used in folk medicine for its antiseptic, astringent and antispasmodic effects (Le Floc'h [<reflink idref="bib28" id="ref14">28</reflink>]). This species possess a high content of naphtodianthrones, which might be used against viruses and retroviruses, and considerable amounts of phloroglucinol with potential antibacterial and cytotoxic activities (Stojanović et al. [<reflink idref="bib44" id="ref15">44</reflink>]).</p> <p> <emph>Hypericum perfoliatum</emph> L. is a perennial herbaceous species, usually growing in shady places among rocks. It has 20–50 cm height, 15–80 cm stems, 1.5–4.0 cm leaves, ovate to triangular-lanceolate, the upper most sometimes black-glandular-ciliate, usually densely pellucid-dotted, with obscure reticulate venation. The species has oblong, subacute to rounded sepals, which are densely and irregularly dark-glandular denticulate; petals 2–3 times great than calice, with black dotes. Its fruit is a 0.5–0.6 cm capsule, ovate or obovate, with dorsal vittae and lateral vesicles (Çirak [<reflink idref="bib11" id="ref16">11</reflink>]; Del Monte et al. [<reflink idref="bib14" id="ref17">14</reflink>]; Pottier-Alapetite 1979). <emph>Hypericum perfoliatum</emph> has great pharmaceutical potential (Sarrell et al. [<reflink idref="bib41" id="ref18">41</reflink>]), with well documented contents of hypericin (Ayan et al. [<reflink idref="bib4" id="ref19">4</reflink>]), phenolics, phloroglucinols (Benkiki et al. [<reflink idref="bib5" id="ref20">5</reflink>]) and essential oils (Couladis et al. [<reflink idref="bib13" id="ref21">13</reflink>]; Çirak et al. [<reflink idref="bib10" id="ref22">10</reflink>]).</p> <p> <emph>Hypericum perforatum</emph> L. is the most studied taxon (Vinterhalter et al. [<reflink idref="bib48" id="ref23">48</reflink>]). It is used for the extraction of several bioactive compounds known for their photodynamic, antidepressive and antiviral activities (Patocka [<reflink idref="bib38" id="ref24">38</reflink>]). The other species remain little known with regard to their chemical composition especially for their hypericin and hyperforin content, the most studied molecules from the genus. Both <emph>in vitro</emph> and <emph>in vivo</emph> studies, hypericin significantly inhibited viruses such as HIV (Human immunodeficiency virus) 35, Influenza A, Human cytomegalovirus (HCMV), the DNA-virus, i.e. Herpes simplex (type 1 and type 2) (Westh et al. [<reflink idref="bib49" id="ref25">49</reflink>]; Fritz et al. [<reflink idref="bib18" id="ref26">18</reflink>]).</p> <p>In an attempt to broaden our knowledge of chemical composition of Tunisian medicinal flora, we have undertaken an analysis of total phenolic and flavonoid content, concentration in hypericin and hyperforin in <emph>H. humifusum</emph> and <emph>H. perfoliatum</emph> as well as their biological activities including antioxidant, antimicrobial, acetylcholinesterase, α-amylase and α-glucosidase inhibitory effect.</p> <hd id="AN0126815675-3">Materials and methods</hd> <p></p> <hd id="AN0126815675-4">Chemicals and reagents</hd> <p>Folin–Ciocalteu reagent, 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,4,6 tripyridyl-s-triazine (TPTZ), 6-hydroxy-2,5,7,8-tetramethylchroman-2carboxylic acid (Trolox), iron(III) chloride hexahydrate (FeCL<subs>3</subs>·6H<subs>2</subs>O), Iron(II) chloride tetrahydrate (FeCl<subs>2</subs>·4H<subs>2</subs>O), ferrozine, iron(II) sulfate heptahydrate (FeSO<subs>4</subs>·7H<subs>2</subs>O), potassium iodide (KI), α-amylase, α-glucosidase and acetylcholinesterase were purchased from Sigma-Aldrich (St. Louis, MO). All solvents and reagents used in this study are of higher purity.</p> <hd id="AN0126815675-5">Plant materials</hd> <p> <emph>Hypericum humifusum</emph> L. and <emph>H. perfoliatum</emph> L. were collected from the northern west of the country from the sub-humid bioclimate during summer 2007 from Tunisia. Botanical identification of this species was carried out by Prof. Mohamed Boussaid, biologist (National Institute of Applied Science and Technology, Tunisia). Voucher specimens were deposited at the herbarium of INSAT.</p> <hd id="AN0126815675-6">Extraction</hd> <p>Approximately 10 g of each plant was powdered, and then extracted with 100 mL MeOH under stirring at 200 rpm for 4 days. The solutions were filtered and concentrated under reduced pressure to evaporate the solvent and then dried under nitrogen flow. The residue was redissolved in MeOH and then stored at −20 °C until further analysis.</p> <hd id="AN0126815675-7">Determination of total phenolics</hd> <p>Total phenolics contents were assayed using the Folin–Ciocalteu reagent and gallic acid as a standard following Capocasa et al. ([<reflink idref="bib8" id="ref27">8</reflink>]), and Veberic et al. ([<reflink idref="bib47" id="ref28">47</reflink>]). Folin–Ciocalteu reagent (1.5 mL) was added to a solution containing 0.5 mL of extract, with a known concentration (1 mg/mL). The solution was mixed and after 5 min, 1.5 mL of 7.5% sodium carbonate solution was added. The mixture was left to incubate for 90 min, and the absorbance was measured at 760 nm. The total phenolics content was calculated by a standard gallic acid graph, and the results expressed in mg of gallic acid equivalents per g (mg GAE/g) of dry weight of extract. The assay was performed in triplicate for each extract.</p> <hd id="AN0126815675-8">Determination of total flavonoids</hd> <p>The total flavonoids contents in the various extracts were determined according to Djeridane et al. ([<reflink idref="bib16" id="ref29">16</reflink>]) using a method based on the formation of a complex flavonoid-aluminum, having the maximum absorbance at 430 nm. Quercetin was used to make the calibration curve. About 1 mL of diluted sample was mixed with 1 mL of 2% aluminum trichloride (AlCl<subs>3</subs>) methanol solution. After incubation at room temperature for 15 min, the absorbance of the reaction mixture was measured at 430 nm UV-Vis spectrophotometer and the total flavonoid content was expressed in mg quercetin equivalent (QE) per g of extract.</p> <hd id="AN0126815675-9">Determination of hypericin and hyperforin content</hd> <p>Standard solutions of hypericin 0.02 mg/mL and hyperforin 0.05 mg/mL were prepared in MeOH and stored at −18 °C. Plant extracts of various concentrations (0.02–1.00 mg/mL) were prepared by successive dilutions of a stock solution of 10 mg of dry extracts dissolved in 10 mL of methanol (Stalikas &amp; Konidari [<reflink idref="bib43" id="ref30">43</reflink>]). Spectrophotometric measurements were performed on a UV-vis spectrophotometer at 590 nm for hypericin and 287 nm for hyperforin.</p> <hd id="AN0126815675-10">Antioxidant activities</hd> <p></p> <hd id="AN0126815675-11">Free radical-scavenging activity</hd> <p>The evaluation of the free radical-scavenging activity was based on the measurement of the reducing ability of antioxidants toward the DPPH radical following the method described by Hatano et al. ([<reflink idref="bib23" id="ref31">23</reflink>]) with some modifications. Various concentrations of the diluted extract were mixed with 0.50 mL DPPH (0.2 mM in meOH). The mixture was then shaken and allowed to stand at room temperature in the dark. After 30 min, the decrease in absorbance was measured at 517 nm against a blank (methanol solution) using a UV-vis spectrophotometer. A mixture consisting of 0.50 mL of methanol and 0.25 mL of DPPH solution was used as the control.</p> <p>The capability to scavenge the DPPH radical was calculated using the following equation: RSA (%) = 100 × (A blank – A sample)/A blank; where A blank is the absorbance of the control reaction (containing all reagents except the test compound) and A sample is the absorbance of the test compound. Trolox was used as the positive control. Three replicates of sample were recorded. The results are expressed as Trolox equivalents (mg TEs/g).</p> <hd id="AN0126815675-12">Ferric reducing antioxidant power assay (FRAP)</hd> <p>The FRAP assay was adapted from Gardeli et al. ([<reflink idref="bib19" id="ref32">19</reflink>]). The FRAP reagent was freshly prepared by mixing TPTZ solution (10 mM TPTZ in 40 mM HCl), ferric solution (FeCl<subs>3</subs>·6H<subs>2</subs>O, 20 mM) and acetate buffer (300 mM, pH 3.6) in proportions of 1:1:10 (v/v). To perform the assay, 900 μL of FRAP working reagent were mixed with 90 μL distilled water. 30 μL of diluted oil were then added and incubated at 37 °C in a water bath for 30 min. Absorbance at 593 nm was determined against distilled water blank. Ferrous sulfate heptahydrate solutions (100–2000 μM) were used for calibration. The FRAP values were expressed as mmol of Fe<sups>2+</sups>/g DW. All assays were determined in triplicate.</p> <hd id="AN0126815675-13">Free radical-scavenging ability by the use of a stable ABTS radical cation</hd> <p>The method is based on the ability of antioxidant molecules to quench the long-lived 2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) radical cation (ABTS<sups>+</sups>), compared with that of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid). A stable stock solution of ABTS<sups>+ </sups>was produced by reacting a 7 mmol aqueous solution of ABTS with 2.45 mmol ammonium persulfate (final concentration), and allowing the mixture to stand in the dark at room temperature for 12–16 h before use (Re et al. [<reflink idref="bib40" id="ref33">40</reflink>]). At the beginning of the analysis day, an ABTS<sups>+ </sups>working solution was obtained by diluting the stock solution with ethanol, to an absorbance of 0.70 ± 0.02 at 734 nm, verified with a UV-vis spectrophotometer. <emph>Hypericum</emph> aerial parts were centrifuged at 2800 <emph>g</emph> for 10 min and the supernatant was collected for analysis. Supernatant (10 μL) was mixed with the working solution, to a final volume of 1 mL. The inhibition percentage I(%) of radical scavenging activity was calculated as: I(%) = 100 × (A0 − AS)/A0, where A0 is the absorbance of the control and AS is the absorbance of the sample after 4 min of incubation. Trolox (in the range from 1.0 to 50 μM) was used as a reference standard. TEAC were expressed as μM of Trolox equivalents (TE), referring to 1 mL of extract.</p> <hd id="AN0126815675-14">Metal chelating activity</hd> <p>The chelating of ferrous ions by Hhu and Hper extracts was estimated as described by Dinis et al. ([<reflink idref="bib15" id="ref34">15</reflink>]). Different concentrations of extracts were added to a 0.3 mL FeCl<subs>2</subs>·4H<subs>2</subs>O solution (1 mmol/L) and left for incubation for 5 min. The reaction was initiated by adding 0.3 mL of ferrozine (25 mmol/L). Absorbance of the solution was then measured spectrophotometrically at 562 nm. The percentage of inhibition of ferrozine-Fe<sups>2 + </sups>complex formation was calculated using the formula given bellow:</p> <p>Metal chelating effect (%) = (A0 − A1)/A0 × 100; where, A0 is the absorbance of the control, and A1 is the absorbance in the presence of the sample or standard. Analyses were run in triplicates.</p> <hd id="AN0126815675-15">Enzyme inhibitory activity</hd> <p>Acetylcholinesterase (AChE) inhibitory activity was measured using Ellman's method, as previously reported (Zengin et al. [<reflink idref="bib50" id="ref35">50</reflink>]). α-Amylase and α-glucosidase inhibitory activities were carried out by the method described by Zengin et al. ([<reflink idref="bib50" id="ref36">50</reflink>]).</p> <hd id="AN0126815675-16">Antimicrobial activity</hd> <p></p> <hd id="AN0126815675-17">Microbial strains</hd> <p>Extracts from Hhu and Hper were individually tested against a panel of microorganisms including Gram-positive bacteria and Gram-negative bacteria. Micro-organisms were provided from the culture collection of the Laboratory of Natural Substances, at National Institute of Research and Physico-chemical Analysis. The Gram-positive bacteria were <emph>Staphylococus aureus</emph> (strain ATCC 6538), <emph>Staphylococcus epidermidis</emph> (strain ATCC 12228), <emph>Bacillus subtilis</emph> (an environmental isolate), <emph>Enterococcus faecium</emph> (strain ATCC 19434), and the Gram-negative bacteria were <emph>Escherichia coli</emph> (strain ATCC 8739), <emph>Salmonella typhimurium</emph> (strain ATCC 14028), <emph>Pseudomonas aeruginosa</emph> (strain NCTC 10418), and <emph>Pseudomonas aeruginosa</emph> (strain ATCC 27853) and yeast <emph>Candida albicans</emph>.</p> <hd id="AN0126815675-18">Disc diffusion method</hd> <p>A suspension of the tested microorganisms was spread on the solid Mueller–Hinton media plates and incubated overnight at 37 °C. After 1 day, 4–5 loops of pure culture were transferred to saline solution in a test tube for each bacterial strain. Sterile cotton dipped into the bacterial suspension and 0.5 mL from each strand was transferred into Mueller–Hinton (M-H) agar plate. On a MHA plate were inoculated with a bacterial suspension of 0.5 McFarland turbidity standards at a density of 10<sups>8</sups> cells/mL. The MeOH extracts were dissolved in 10% aqueous dimethylsulfoxide (DMSO) equivalent to 200 μg/mL, sterilized by filtering through a 0.22 μM filter and sterile paper discs and placed onto inoculated plates. The inoculum for each strain was prepared from broth cultures. Ampicillin (10 μg/disc) and Gentamicin (10 μg/disc) (USP grade, BIOMATIK, Germany) were used as positive standards in order to control the sensitivity of the microorganisms. Antibiotic disc was used for each plate and run in duplicate. Inoculated plates with discs were placed in a 37 °C incubator. After 24 h of incubation, the results were recorded by measuring the zones of growth inhibition surrounding the disc. Clear inhibition zones around the discs indicated the presence of antimicrobial activity.</p> <hd id="AN0126815675-19">Determination of minimum inhibitory (MIC) concentration</hd> <p>The MIC was determined using microdilution method recommended by Clinical and Laboratory Standards Institute (NCCLS [<reflink idref="bib32" id="ref37">32</reflink>], [<reflink idref="bib33" id="ref38">33</reflink>]). The inoculum was prepared using a 24 h culture adjusted by reference to the McFarland standard and further diluted with sterile physiological saline solution to achieve approximately 10<sups>6</sups> CFU/mL. A sterile 96-well microplates was used for each strain and set up as follows: in wells in raw A to G were placed 100 μL of the oil dilution added to 5 μL of the inoculum and 95 μL of the sterile MH broth. These wells are duplicated for each extract. A positive control (containing inoculum but no extract) and negative control (containing extract but no inoculum) were included on each microplate. The contents of the wells were mixed and the microplates were incubated at 37 °C for 24 h. After incubation, a 10 μL of a 5 mg/mL MTT solution, the viability of bacteria is determined by the MTT assay. In fact, MTT staining method is selected as the color with the chemical reaction of the reduction of the salt (bromide 3 (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), which is yellow in blue crystals of formazan blue, were added to each well and the plates were left stirring for 30 min at room temperature.</p> <p>For MBC determination, the contents of the wells showing growth inhibition were streaked onto the surface of nutrient agar plates and incubated at 37 °C for 24 h. After the incubation, the plates were observed for growth.</p> <p>The MBC was estimated as the least concentration of the extract where no visible growth was observed. The MIC was defined as the lowest concentration of the total essential oil at which the microorganism does not demonstrate visible growth (Okeke et al. [<reflink idref="bib37" id="ref39">37</reflink>]).</p> <hd id="AN0126815675-20">Statistical analysis</hd> <p>All assays were run in triplicate. The results are reported as mean values of three analyses along with the standard deviation. Data were subjected to statistical analysis using the SPSS programme, release 11.0 for Windows (SPSS, Chicago, IL). The one-way analysis of variance (ANOVA) followed by Duncan's multiple range test were employed to study the differences between means. Values of <emph>p</emph> &lt; 0.05 and <emph>p</emph> &lt; 0.01 were considered statistically significant and highly significant, respectively.</p> <hd id="AN0126815675-21">Results and discussion</hd> <p></p> <hd id="AN0126815675-22">Chemical composition of H. humifusum and H. perfoliatum extracts</hd> <p>The mean yields ranged from 6.9% to 11.3% for <emph>H. perfoliatum</emph> and <emph>H. humifusum</emph>, respectively. Yields were then estimated on the basis of the dry weight of plant material.</p> <p>The pharmaceutical activity of <emph>H</emph>. <emph>humifusum</emph> and <emph>H</emph>. <emph>perfoliatum</emph>, is attributed mainly to hypericin and hyperforin (Skalkos et al. [<reflink idref="bib42" id="ref40">42</reflink>]). Table 1 summarizes the results from the quantitative determination of the two major components of the extracts and their respective total phenolic and flavonoid contents. The PC value of <emph>H. humifusum</emph> (113.52 ± 4 g gallic acid equivalents/g DW) was statistically higher (one-way ANOVA and Duncan's tests, <emph>p</emph> &lt; 0.001) than that of <emph>H. perfoliatum</emph> (52.46 mg gallic acid equivalents/g DW). The TF content of <emph>H. humifusum</emph> (41.06 mg RE/g DW) is statistically higher than that of <emph>H. perfoliatum</emph> (Table 1). Results of hypericin and hyperforin content are in accordance with those obtained in TP and TF determination. The highest concentration of hypericin and hyperforin was observed in <emph>H</emph>. <emph>humifusum</emph> (<reflink idref="bib90" id="ref41">90</reflink>, and 30 mg/g DW, respectively) when compared to that of <emph>H. perfoliatum</emph> (60 and 8.5 mg/g DW, respectively).</p> <p>Table 1. Phenolic content and concentrations of hypericin and hyperforin in H. humifusum and H. perfoliatum extracts.</p> <p> <ephtml> &lt;table&gt;&lt;thead&gt;&lt;tr&gt;&lt;td /&gt;&lt;td&gt;Hypericin (mg/g of dry extract)&lt;/td&gt;&lt;td&gt;Hyperforin (mg/g of dry extract)&lt;/td&gt;&lt;td&gt;TPC&lt;xref ref-type="table-fn" rid="TF3"&gt;b&lt;/xref&gt; [mg GAE/g]&lt;/td&gt;&lt;td&gt;TF&lt;xref ref-type="table-fn" rid="TF4"&gt;c&lt;/xref&gt; [mg RE/g]&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign="top"&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Hypericum humifusum&lt;/italic&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;90&amp;#8201;&amp;#177;&amp;#8201;1&lt;xref ref-type="table-fn" rid="TF2"&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;30&amp;#8201;&amp;#177;&amp;#8201;0.09&lt;xref ref-type="table-fn" rid="TF2"&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;113.52&amp;#8201;&amp;#177;&amp;#8201;4&lt;xref ref-type="table-fn" rid="TF2"&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;41.06&amp;#8201;&amp;#177;&amp;#8201;0.8&lt;xref ref-type="table-fn" rid="TF2"&gt;a&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Hypericum perfoliatum&lt;/italic&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;60&amp;#8201;&amp;#177;&amp;#8201;0.9&lt;xref ref-type="table-fn" rid="TF3"&gt;b&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;8.5&amp;#8201;&amp;#177;&amp;#8201;0.2&lt;xref ref-type="table-fn" rid="TF3"&gt;b&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;48.47&amp;#8201;&amp;#177;&amp;#8201;0.2&lt;xref ref-type="table-fn" rid="TF3"&gt;b&lt;/xref&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;8.45&amp;#8201;&amp;#177;&amp;#8201;0.1&lt;xref ref-type="table-fn" rid="TF3"&gt;b&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </ephtml> </p> <ulist> <item>2 Different superscript letters (a and b) in the same column indicate significant difference (<emph>p</emph> &lt; 0.05).</item> </ulist> <p>1 TPC: total phenolic compounds; TF: total flavonoids.</p> <ulist> <item>2 Results are reported as mean ± standard deviation of three replicates (95% confidence).</item> <item>3 mg gallic acid equivalents/g dry weight.</item> <item>4 mg quercetin equivalents/g dry weight, d: mg.</item> </ulist> <hd id="AN0126815675-23">Antioxidant activities</hd> <p>The antioxidant capacities of <emph>H. humifusim</emph> and <emph>H. perfoliatum</emph> extracts were assayed with forth different assays in thus study: free radical scavenging (DPPH and ABTS), reducing power FRAP and metal chelating assays.</p> <p>Free radical scavenging capacities were measured using DPPH radical and ABTS radical cation. The results are expressed as Trolox equivalents (mg TEs/g) and are given in Table 2. <emph>Hypericum humifusum</emph> with 84.63 μmoles Trolox for DPPH and 180.87 mg TEs/g for ABTS exerted greater activity than that of <emph>H. perfoliatum</emph> in both assays (Table 2). This potentiality is mostly correlated to the type of phenolic compounds according to species (Tawaha et al. [<reflink idref="bib45" id="ref42">45</reflink>]).</p> <p>Table 2. Radical scavenging, reducing power and metal chelating activities of MeOH extracts.</p> <p> <ephtml> &lt;table&gt;&lt;thead&gt;&lt;tr&gt;&lt;td /&gt;&lt;td&gt;&lt;italic&gt;H. humifusum&lt;/italic&gt;&lt;/td&gt;&lt;td&gt;&lt;italic&gt;H. perfoliatum&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign="top"&gt;&lt;tr&gt;&lt;td&gt;Radical scavenging activity&lt;/td&gt;&lt;td char="&amp;#177;" /&gt;&lt;td char="&amp;#177;" /&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;#8195;DPPH&lt;xref ref-type="table-fn" rid="TF6"&gt;b&lt;/xref&gt; [&amp;#956;moles Trolox/g]&lt;/td&gt;&lt;td char="&amp;#177;"&gt;84.63&amp;#8201;&amp;#177;&amp;#8201;1.62&lt;/td&gt;&lt;td char="&amp;#177;"&gt;52.31&amp;#8201;&amp;#177;&amp;#8201;1.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;#8195;ABTS&lt;xref ref-type="table-fn" rid="TF6"&gt;b&lt;/xref&gt; radical cation (mg TEs/g)&lt;/td&gt;&lt;td char="&amp;#177;"&gt;180.87&amp;#8201;&amp;#177;&amp;#8201;1.8&lt;/td&gt;&lt;td char="&amp;#177;"&gt;80.6&amp;#8201;&amp;#177;&amp;#8201;1.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Reducing power&lt;/td&gt;&lt;td char="&amp;#177;" /&gt;&lt;td char="&amp;#177;" /&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;#8195;FRAP&lt;xref ref-type="table-fn" rid="TF6"&gt;b&lt;/xref&gt; [mmol Fe&lt;sup&gt;2+&lt;/sup&gt;/g]&lt;/td&gt;&lt;td char="&amp;#177;"&gt;80.23&amp;#8201;&amp;#177;&amp;#8201;0.07&lt;/td&gt;&lt;td char="&amp;#177;"&gt;50&amp;#8201;&amp;#177;&amp;#8201;0.07&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Metal chelating&lt;/td&gt;&lt;td char="&amp;#177;" /&gt;&lt;td char="&amp;#177;" /&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&amp;#8195;Ferrous ion chelating (mg EDTAEs/g)&lt;/td&gt;&lt;td char="&amp;#177;"&gt;3.7&amp;#8201;&amp;#177;&amp;#8201;0.08&lt;/td&gt;&lt;td char="&amp;#177;"&gt;8.76&amp;#8201;&amp;#177;&amp;#8201;0.08&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </ephtml> </p> <ulist> <item>5 Results are reported as mean ± standard deviation of three replicates (95% confidence).</item> <item>6 μM Trolox equivalents (TE).</item> </ulist> <p>The reducing power may serve as significant indicator of its potential antioxidant activity. For these reason, ferric reducing power was examined (Table 2). Consistent with DPPH and ABTS radical scavenging capacity, reducing power of Hhu showed significantly higher than Hper. From these results, it seems to be hypercin and hyperforin are excellent reductants in these assays.</p> <p>The chelating effects of ferrous ions were estimated. In this assay, the MeOH extracts interfered with the formation of Fe<sups>2+ </sups>and ferrozine complex, thus they have chelating activity and can capture Fe<sups>2+ </sups>before ferrozine. As shown in Table 2, Hper (8.76 mg EDTAEs/g), in contrast to other assays, recorded higher metal chelating activity than that of Hhu (3.7 mg EDTAEs/g). Interestingly, though Hper did not have high free radical scavenging and reducing capacities, it exhibited the superior activity in metal chelating assays. This can be explained by the fact that Hper has high concentration of other molecules with high metal chelating activity. These results are in good agreement with Nithiyanantham et al. ([<reflink idref="bib34" id="ref43">34</reflink>]) who reported that the metal chelating capacity of phytochemicals depend on hydroxyl substitution in the structure.</p> <hd id="AN0126815675-24">Enzyme inhibitory activity</hd> <p>Cholinesterase inhibitors serve as a strategy for the treatment of Alzheimer's diseases, which is a neurodegenerative disorder. They promote an increase in the level of acetylcholine in neuronal synaptic area (Mukherjee et al. [<reflink idref="bib30" id="ref44">30</reflink>]). In this direction, the search for novel and safe acetylcholinesterase inhibitors from natural resources with better properties is necessary for the treatment of Alzheimer's disease. The MeOH extracts showed a similar action on AChE (4.57 mg for Hhu and 3.86 mg GALAEs/g for Hper, respectively) (Table 3). Previously, some authors reported that <emph>Hypericum</emph> species were recommended for the treatment of Alzheimer's diseases (Hofrichter et al. [<reflink idref="bib24" id="ref45">24</reflink>]). In these publications, the cholinesterase inhibitory property was associated with the main components of <emph>Hypericum</emph> species. However, inhibitory activity of Hhu and Hper on AChE may be due to the high level of hypericin.</p> <p>Table 3. Enzyme inhibitory activity of the MeOH extracts (mean ± SD).</p> <p> <ephtml> &lt;table&gt;&lt;thead&gt;&lt;tr&gt;&lt;td&gt;Samples&lt;/td&gt;&lt;td&gt;Acetyl cholinesterase (mg GALAEs/g)&lt;/td&gt;&lt;td&gt;&amp;#945;-Amylase (mmol ACEs/g)&lt;/td&gt;&lt;td&gt;&amp;#945;-Glucosidase (mmol ACEs/g)&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign="top"&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Hypericum humifusum&lt;/italic&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;4.57&amp;#8201;&amp;#177;&amp;#8201;0.3&lt;/td&gt;&lt;td char="&amp;#177;"&gt;2.55&amp;#8201;&amp;#177;&amp;#8201;0.08&lt;/td&gt;&lt;td char="&amp;#177;"&gt;8&amp;#8201;&amp;#177;&amp;#8201;0.08&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Hypericum perfoliatum&lt;/italic&gt;&lt;/td&gt;&lt;td char="&amp;#177;"&gt;3.86&amp;#8201;&amp;#177;&amp;#8201;0.02&lt;/td&gt;&lt;td char="&amp;#177;"&gt;0.73&amp;#8201;&amp;#177;&amp;#8201;0.04&lt;/td&gt;&lt;td char="&amp;#177;"&gt;3.88&amp;#8201;&amp;#177;&amp;#8201;0.07&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </ephtml> </p> <p>8 GALAEs: galanthamine equivalents; ACEs: acarbose equivalents.</p> <p>Diabetes mellitus is one of the major public health problems. It is characterized by chronic hyperglycemia with disturbance of glucose metabolism resulting from the defect in insulin secretion (Dong et al. [<reflink idref="bib17" id="ref46">17</reflink>]). α-Amylase and α-glucosidase are key enzymes in hydrolysis of starch and oligosaccharide (Gray [<reflink idref="bib21" id="ref47">21</reflink>]). The inhibition of these enzymes is an important strategy in the management blood glucose level. It is important to evaluate the anti-diabetic properties of medicinal plants and their products to develop natural compounds with low toxicity. Antidiabetic activity was investigated by α-amylase and α-glucosidase inhibitory assays. As shown in Table 3, the highest α-glucosidase inhibitory activity was recorded in the Hhu with 8 mmol ACEs/g. in the same way α-amylase inhibitory activity of Hhu (2.55 mmol ACEs/g) was higher than that of Hper (0.73 mmol ACEs/g). The anti-diabetic activity of the extracts is related to main components. Gulam et al. ([<reflink idref="bib22" id="ref48">22</reflink>]) demonstrated that hyperforin is responsible for the antidiabetic activity.</p> <hd id="AN0126815675-25">Antimicrobial activity</hd> <p>The antimicrobial activity of extracts was examined by disc diffusion and microdilution susceptibility assay against eight bacterial and one yeast strains.</p> <p>The extracts exhibited variable MICs and important antimicrobial activity, depending on the microbial strains (Table 4). <emph>Hypericum humifusum</emph> showed very strong activity against <emph>E. coli</emph>, <emph>Pseudomona</emph> sp. and <emph>Bacillus subtilis</emph> (200-250 μg mL<sups>−1</sups>). The highest MIC for <emph>Salmonella typhimurium</emph> was 500 μg/mL, whereas the lowest MIC was 200 μg/mL for <emph>Bacillus subtilis</emph>. Mukherjee et al. ([<reflink idref="bib31" id="ref49">31</reflink>]) reported that the leaf of <emph>H. mysorense</emph> and <emph>H. patulum</emph> have a very broad spectrum against panel of microorganisms.</p> <p>Table 4. MIC and MBC results of of H. humifusum and H. perfoliatum extracts against selected bacterial and yeast strains.</p> <p> <ephtml> &lt;table&gt;&lt;thead&gt;&lt;tr&gt;&lt;td /&gt;&lt;td&gt;&lt;italic&gt;CON+&lt;/italic&gt;&lt;/td&gt;&lt;td&gt;&lt;italic&gt;H. humifusum&lt;/italic&gt;&lt;/td&gt;&lt;td&gt;&lt;italic&gt;H. perfoliatum&lt;/italic&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Bacterial strain&lt;/td&gt;&lt;td&gt;MIC&lt;/td&gt;&lt;td&gt;MBC&lt;/td&gt;&lt;td&gt;MIC&lt;/td&gt;&lt;td&gt;MBC&lt;/td&gt;&lt;td&gt;MIC&lt;/td&gt;&lt;td&gt;MBC&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody valign="top"&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Escherichia coli&lt;/italic&gt; G(&amp;#8722;)&lt;/td&gt;&lt;td char="."&gt;18.5&lt;/td&gt;&lt;td char="."&gt;25&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;500&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;600&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Salmonella typhimurium&lt;/italic&gt; G(&amp;#8722;)&lt;/td&gt;&lt;td char="."&gt;15&lt;/td&gt;&lt;td char="."&gt;24&lt;/td&gt;&lt;td char="."&gt;500&lt;/td&gt;&lt;td char="."&gt;550&lt;/td&gt;&lt;td char="."&gt;500&lt;/td&gt;&lt;td char="."&gt;650&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Pseudomonas aeruginosa&lt;/italic&gt; G(&amp;#8722;)&lt;/td&gt;&lt;td char="."&gt;1.6&lt;/td&gt;&lt;td char="."&gt;3.5&lt;/td&gt;&lt;td char="."&gt;300&lt;/td&gt;&lt;td char="."&gt;600&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;650&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Pseudomonas aeruginosa&lt;/italic&gt; G(&amp;#8722;)&lt;/td&gt;&lt;td char="."&gt;1&lt;/td&gt;&lt;td char="."&gt;2.5&lt;/td&gt;&lt;td char="."&gt;300&lt;/td&gt;&lt;td char="."&gt;600&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;600&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Enterococcus faecium&lt;/italic&gt; G(+)&lt;/td&gt;&lt;td char="."&gt;10.5&lt;/td&gt;&lt;td char="."&gt;13&lt;/td&gt;&lt;td char="."&gt;250&lt;/td&gt;&lt;td char="."&gt;400&lt;/td&gt;&lt;td char="."&gt;450&lt;/td&gt;&lt;td char="."&gt;500&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Staphylococus aureus&lt;/italic&gt; G(+)&lt;/td&gt;&lt;td char="."&gt;5&lt;/td&gt;&lt;td char="."&gt;10.5&lt;/td&gt;&lt;td char="."&gt;250&lt;/td&gt;&lt;td char="."&gt;400&lt;/td&gt;&lt;td char="."&gt;300&lt;/td&gt;&lt;td char="."&gt;400&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Staphylococcus epidermidis&lt;/italic&gt; G(+)&lt;/td&gt;&lt;td char="."&gt;6.5&lt;/td&gt;&lt;td char="."&gt;12&lt;/td&gt;&lt;td char="."&gt;200&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;450&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Bacillus subtilis&lt;/italic&gt; G(+)&lt;/td&gt;&lt;td char="."&gt;15&lt;/td&gt;&lt;td char="."&gt;30&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;450&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;italic&gt;Candida albicans&lt;/italic&gt;&lt;/td&gt;&lt;td char="."&gt;5&lt;/td&gt;&lt;td char="."&gt;11.5&lt;/td&gt;&lt;td char="."&gt;300&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;td char="."&gt;250&lt;/td&gt;&lt;td char="."&gt;350&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </ephtml> </p> <ulist> <item>9 CON+: positive control, antibiotic: Ampicillin for all strains except for <emph>Pseudomonas aeruginosa</emph> where positive control and Gentamicin.</item> <item>10 MIC: minimal inhibitory concentration (μg mL<sups>−1</sups>).</item> <item>11 MIC was defined as the lowest concentration of the compounds produced &gt;95% growth reduction compared with the growth in the control well.</item> <item>12 MBC: minimum bactericidal concentration (μg mL<sups>−1</sups>).</item> </ulist> <p>Extracts from the two species showed a very high bactericidal effect. However, both Hhu (MBC = 500–600 μg/mL) and Hper (MBC = 600–650 μg/mL) showed a high-bactericidal activity against the Gram-negative bacteria <emph>E. coli</emph>, <emph>S. typhimurium</emph> and <emph>P. aeruginosa</emph>. The lowest MBC values have been detected against the two Gram-positive bacteria <emph>S. epidermidis</emph> and <emph>B. subtilis</emph> for Hhu and <emph>Candida albicans</emph> for Hper.</p> <p> <emph>Hypericum</emph> genus has been found to yield compounds having antimicrobial property. Inhibitory effects of <emph>H. perforatum</emph> on Gram-positive bacteria have also been observed and attributed to hyperforin, the main acylphloroglucinol isolated from this plant. Phloroglucinol derivatives, found frequently in the lipophilic (Avato et al. [<reflink idref="bib3" id="ref50">3</reflink>]) fractions of several <emph>Hypericum</emph> species, have demonstrated antibacterial activities against microorganisms such as <emph>S. aureus</emph>, <emph>B. cereus</emph>, <emph>B. subtilis</emph> and <emph>Nocardia gardenen</emph>. The <emph>Staphylococcus</emph> species have been identified as the leading bacteria which are mostly studied in terms of their interaction with this genus. <emph>Escherichia coli</emph>, <emph>Mycobacterium</emph> sp., <emph>Staphylococcus</emph> sp., <emph>Streptococcus</emph> sp. have been commonly used for determination of antimicrobial effect of <emph>H. humifusum</emph> (Nogueira et al. [<reflink idref="bib36" id="ref51">36</reflink>]). Gibbons et al. ([<reflink idref="bib20" id="ref52">20</reflink>]) showed the impact of the chloroform and methanol extracts of 34 different species of <emph>Hypericum</emph> on <emph>Staphylococcus</emph>. According to the results, it has been emphasized that <emph>Hypericum</emph> genus is of a great potential for anti-staphylococcal effect.</p> <hd id="AN0126815675-26">Conclusions</hd> <p> <emph>Hypericum</emph> species have become a popular area for many scientific researches. It has been estimated that it would be a significant material for both biological and chemical studies mainly for its availability and widespread distribution. In this study, a large number of chemical studies on <emph>H. humifusum</emph> and <emph>H. perfoliatum</emph> have been reviewed. Both species showed a good phenolic, flavonoid, hypericin and hyperforin content which explain their high-antioxidant capacities as evaluated by four <emph>in vitro</emph> assays. However, the first species seems to be more important as a source of these natural compounds. It also showed a better potential biological activity as enzyme inhibitors and antimicrobial agents.</p> <hd id="AN0126815675-27">Acknowledgements</hd> <p>The authors express their gratitude to the Ministry of Higher Education and Scientific Research- Tunisia and the National Institute of Research and Physico-Chemical Analysis (Research grant LR15INRAP02).</p> <hd id="AN0126815675-28">Disclosure statement</hd> <p>The authors declare that there are no conflicts of interest.</p> <ref id="AN0126815675-29"> <title> References </title> <blist> <bibl id="bib1" idref="ref2" type="bt">1</bibl> <bibtext> Agostinis P, Vantieghem A, Merlevede W, De Witte PAM. 2002. Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol. 34:221–241.</bibtext> </blist> <blist> <bibl id="bib2" idref="ref8" type="bt">2</bibl> <bibtext> Ali M, Arfan M, Ahmad H, Zaman K, Khan F, Amarowicz R. 2011. Comparative antioxidant and antimicrobial activities of phenolic compounds extracted from five Hypericum species. Food Technol Biotechnol. 49:205–213.</bibtext> </blist> <blist> <bibl id="bib3" idref="ref50" type="bt">3</bibl> <bibtext> Avato P, Raffo F, Guglielmi G, Vitali C, Rosato A. 2004. Extracts from St John's Wort and their antimicrobial activity. Phytother Res. 18:230–232.</bibtext> </blist> <blist> <bibl id="bib4" idref="ref19" type="bt">4</bibl> <bibtext> Ayan AK, Cırak C, Kevseroglu K, Mzen T. 2004. Hypericin in some Hypericum species from Turkey. Asian J Plant Sci. 3:200–202.</bibtext> </blist> <blist> <bibl id="bib5" idref="ref20" type="bt">5</bibl> <bibtext> Benkiki N, Kabouche Z, Tillequin F, Verite P, Chosson E, Seguin E. 2003. A new polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae). Z Nat Forsch. 58:655–658.</bibtext> </blist> <blist> <bibl id="bib6" idref="ref5" type="bt">6</bibl> <bibtext> Butterwerck V, Jürgenliemk G, Nahrstedt A, Winterhoff H. 2000. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med. 66:3–6.</bibtext> </blist> <blist> <bibl id="bib7" idref="ref7" type="bt">7</bibl> <bibtext> Cakir A, Mavi A, Yildirim A, Duru ME, Harmandar M, Kazaz C. 2003. Isolation and characterization of antioxidant phenolic compounds from the aerial parts of Hypericum hyssopifolium L. by activity-guided fractionation. J Ethnopharmacol. 87:73–83.</bibtext> </blist> <blist> <bibl id="bib8" idref="ref27" type="bt">8</bibl> <bibtext> Capocasa F, Scalzo J, Mezzetti B, Battino M. 2008. Combining quality and antioxidant attributes in the strawberry: The role of genotype. Food Chem. 111:872–878.</bibtext> </blist> <blist> <bibl id="bib9" idref="ref4" type="bt">9</bibl> <bibtext> Cardile V, Russo A, Formisano C, Rigano D, Senatore F, Arnold NA, Piozzi F. 2009. Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells. J Ethnopharmacol. 126:265–272.</bibtext> </blist> <blist> <bibtext> Çirak C, Radusiene J, Janulis V, Ivanauskas L. 2007. Secondary metabolites in Hypericum perfoliatum: variation among plant parts and phenological stages. Bot Helv. 117:29–36.</bibtext> </blist> <blist> <bibtext> Çirak C. 2007. Seed germination protocols for ex situ conservation of some Hypericum species from Turkey. Am J Plant Physiol. 2:287–294.</bibtext> </blist> <blist> <bibtext> Conforti F, Stati GA, Tundis R, Bianchi A, Agrimonti C, Sacchetti G, Andreotti E, Menichini F, Poli F. 2005. Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L. Nat Prod Res. 19:295–303.</bibtext> </blist> <blist> <bibtext> Couladis M, Baziou P, Petrakis PV, Harvala C. 2001. Essential oil composition of Hypericum perfoliatum L. growing in different locations in Greece. Flavour Fragr J. 16:204–206.</bibtext> </blist> <blist> <bibtext> Del Monte D, De Martino L, Marandino A, Fratianni F, Nazzaro F, De Feo V. 2015. Phenolic content, antimicrobial and antioxidant activities of Hypericum perfoliatum L. Ind Crops Prod. 74:342–347.</bibtext> </blist> <blist> <bibtext> Dinis TC, Madeira VM, Almeida LM. 1994. Action of phenolic derivatives (acetaminophen, salicylate, and 5-amino salicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch Biochem Biophys. 315:161–169.</bibtext> </blist> <blist> <bibtext> Djeridane A, Yousfi M, Nadjemi B, Boutassouna D, Stocker P, Vidal N. 2006. Antioxidant activity of some Algerian medicinal plants extracts containing phenolic compounds. Food Chem. 97:654–660.</bibtext> </blist> <blist> <bibtext> Dong HQ, Li M, Zhu F, Liu FL, Huang JB. 2012. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against alpha-glucosidase and alpha-amylase linked to type 2 diabetes. Food Chem. 130:261–266.</bibtext> </blist> <blist> <bibtext> Fritz D, Venturi C, Cargnin S, Schripsema J, Roehe P, Montan ha J, Von Poser G. 2007. Herpes virus inhibitory substances from Hypericum connatum Lam, a plant used in southern Brazil to treat oral lesions. J Ethnopharmacol. 113:517–520.</bibtext> </blist> <blist> <bibtext> Gardeli C, Vassiliki P, Athanasios M, Kibouris T, Komaitis M. 2008. Essential oil composition of Pistacia lentiscus L. and Myrtus communis: Evaluation of antioxidant capacity of methanolic extracts. Food Chem. 107:1120–1130.</bibtext> </blist> <blist> <bibtext> Gibbons S, Ohlendorf B, Johnsen I. 2002. The genus Hypericum-a valuable resource of anti-Staphylococcal leads. Fitoterapia. 73:300–304.</bibtext> </blist> <blist> <bibtext> Gray DM. 1995. Carbohyrate digestion and absroption-role of small intestine. New Engl J Med. 29:1225–1230.</bibtext> </blist> <blist> <bibtext> Gulam MH, Paras Nath S, Vikas K. 2009. Beneficial effects of a standardized Hypericum perforatum extract in rats with experimentally induced hyperglycemia. Drug Discov Ther. 3:215–220.</bibtext> </blist> <blist> <bibtext> Hatano T, Kagawa H, Yasuhara T, Okuda T. 1988. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. Chem Pharm Bull. 36:1090–2097.</bibtext> </blist> <blist> <bibtext> Hofrichter J, Krohn M, Schumacher T, Lange C, Feistel B, Walbroel B, Heinze H-J, Crockett S, Sharbel T, Pahnke FJ. 2013. Reduced Alzheimer's disease pathology by St. John's wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice. Curr Alzheimer Res. 10:1057–1069.</bibtext> </blist> <blist> <bibtext> Jacobson JM, Feinman L, Liebes L, Ostrow N, Koslowski V, Tobia A, Cabana BE, Lee D, Spritzler J, Prince AM. 2001. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother. 45:517–524.</bibtext> </blist> <blist> <bibtext> Kamatou GPP, Van Zyl RL, Davids H, Van Heerden FR, Lourens ACU, Viljoen AM. 2008. Antimalarial and anticancer activities of selected South African Salvia species and isolated compounds from S. radula. S Afr J Bot. 74:238–243.</bibtext> </blist> <blist> <bibtext> Kizil G, Toker Z, Ozen HC, Aytekin C. 2004. The antimicrobial activity of essential oils of Hypericum scabrum, Hypericum scabroides and Hypericum triquetrifolium. Phytother Res. 18:339–341.</bibtext> </blist> <blist> <bibtext> Le Floc'h E. 1983. Contribution à une étude ethnobotanique de la flore tunisienne. Imp.Off. Rep. Tunisia.</bibtext> </blist> <blist> <bibtext> Matzk F, Hammer K, Shubert I. 2003. Coevolution of apomixis and genome size within the genus Hypericum. Sex Plant Reprod. 16:52–58.</bibtext> </blist> <blist> <bibtext> Mukherjee PK, Kumar V, Mal M, Houghton PJ. 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine. 14:289–300.</bibtext> </blist> <blist> <bibtext> Mukherjee PK, Wahile A, Nazeer AKFH, Rajan S. 2003. Hypericum source of natural antimicrobials. Oriental Pharm Experim Med. 3:111–122.</bibtext> </blist> <blist> <bibtext> NCCLS. 2009a. Methods for dilution Antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A8, Eighth Edition, Wayne, PA.</bibtext> </blist> <blist> <bibtext> NCCLS. 2009b. Performance standard antimicrobial disc susceptibility testing, 10th Edition, M02 A10, Wayne, PA.</bibtext> </blist> <blist> <bibtext> Nithiyanantham S, Selvakumar S, Siddhuraju P. 2012. Total phenolic content and antioxidant activity of two different solvent extracts from raw and processed legumes, Cicer arietinum L. and Pisum sativum L. J Food Compos Anal. 27:52–60.</bibtext> </blist> <blist> <bibtext> Nogueira T, Marcelo-Curto MJ, Cristina Figueiredo A, Barroso Jose G, Pedro LG, Rubiolo P, Bicchi C. 2008. Chemotaxonomy of Hypericum genus from Portugal: Geographical distribution and essential oils composition of Hypericum perfoliatum, Hypericum humifusum, Hypericum linarifolium and Hypericum pulchrum. Biochem Syst Ecol. 36:40–50.</bibtext> </blist> <blist> <bibtext> Nogueira T, Medeiros MA, Marcelo-Curto MJ, García-Pérez BE, Luna-Herrera J, Céu Costa M. 2013. Profile of antimicrobial potential of fifteen Hypericum species from Portugal. Ind Crops Prod. 47:126–131.</bibtext> </blist> <blist> <bibtext> Okeke MI, Iroegbu CU, Eze EN, Okol AS, Esimone CO. 2001. Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity. J Ethnopharmacol. 78:119–127.</bibtext> </blist> <blist> <bibtext> Patocka J. 2003. The chemistry, pharmacology, and toxicology of the biologically active constituents of the herb Hypericum perforatum L. J Appl Biomed. 1:61–73.</bibtext> </blist> <blist> <bibtext> Pottier-Alapetite G. 1979. Flore de la Tunisie: Angiospermes dicotylédones, Apétales-Dialypétales. I.O.R: Tunisie; pp. 654.</bibtext> </blist> <blist> <bibtext> Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 26:1231–1237.</bibtext> </blist> <blist> <bibtext> Sarrell EM, Cohen HA, Kahan E. 2003. Naturopathic treatment for ear pain in children. Pediatrics. 111:574–579.</bibtext> </blist> <blist> <bibtext> Skalkos D, Stavropoulos NE, Tsimaris I, Gioti E, Stalikas CD, Nseyo UO. 2005. The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells. Planta Med. 71:1030–1035.</bibtext> </blist> <blist> <bibtext> Stalikas CD, Konidari CN. 2001. Analysis of malondialdehyde in biological matrices by capillary gas chromatography with electron-capture detection and mass spectrometry. Anal Biochem. 290:108–115.</bibtext> </blist> <blist> <bibtext> Stojanović G, Ðorđević A, Šmelcerović A. 2013. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)? Curr Med Chem. 20:2273–2295.</bibtext> </blist> <blist> <bibtext> Tawaha K, Gharaibeh M, El-Elimat T, Q Alali F. 2010. Determination of hypericin and hyperforin content in selected Jordanian Hypericum species. Ind Crops Prod. 32:241–245.</bibtext> </blist> <blist> <bibtext> Unal EL, Mavi A, Kara AA, Cakir A, Şengül M, Yildirim A. 2008. Antimicrobial and antioxidant activities of some plants used as remedies in Turkish. Trad Med. 46:207–224.</bibtext> </blist> <blist> <bibtext> Veberic R, Colaric M, Stampar F. 2008. Phenolic acids and flavonoids of fig fruit (Ficus carica L.) in the northern Mediterranean region. Food Chem. 106:153–157.</bibtext> </blist> <blist> <bibtext> Vinterhalter B, Ninkovic S, Cingel A, Vinterhalter D. 2006. Shoot and root culture of Hypericum perforatum L. transformed with Agrobacterium rhizogenes A4M70GUS. Biol Plantarum. 50:767–770.</bibtext> </blist> <blist> <bibtext> Westh H, Zinn CS, Rosdahl VT. 2004. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist. 10:169–176.</bibtext> </blist> <blist> <bibtext> Zengin G, Sarikurkcu C, Aktumsek A, Ceylan R, Ceylan O. 2014. A comprehensive study on phytochemical characterization of Haplophyllum myrtifolium Boiss. endemic to Turkey and its inhibitory potential against key enzymes involved in Alzheimer skin diseases and type II diabetes. Ind Crop Prod. 53:244–251.</bibtext> </blist> </ref> <aug> <p>By Afef Béjaoui; Issam Ben Salem; Nesrine Rokbeni; Yassine M'rabet; Mohamed Boussaid and Abdennacer Boulila</p> <p>Reported by Author; Author; Author; Author; Author; Author</p> </aug> <nolink nlid="nl1" bibid="bib27" firstref="ref1"></nolink> <nolink nlid="nl2" bibid="bib26" firstref="ref3"></nolink> <nolink nlid="nl3" bibid="bib25" firstref="ref6"></nolink> <nolink nlid="nl4" bibid="bib46" firstref="ref9"></nolink> <nolink nlid="nl5" bibid="bib12" firstref="ref10"></nolink> <nolink nlid="nl6" bibid="bib39" firstref="ref11"></nolink> <nolink nlid="nl7" bibid="bib29" firstref="ref12"></nolink> <nolink nlid="nl8" bibid="bib35" firstref="ref13"></nolink> <nolink nlid="nl9" bibid="bib28" firstref="ref14"></nolink> <nolink nlid="nl10" bibid="bib44" firstref="ref15"></nolink> <nolink nlid="nl11" bibid="bib11" firstref="ref16"></nolink> <nolink nlid="nl12" bibid="bib14" firstref="ref17"></nolink> <nolink nlid="nl13" bibid="bib41" firstref="ref18"></nolink> <nolink nlid="nl14" bibid="bib13" firstref="ref21"></nolink> <nolink nlid="nl15" bibid="bib10" firstref="ref22"></nolink> <nolink nlid="nl16" bibid="bib48" firstref="ref23"></nolink> <nolink nlid="nl17" bibid="bib38" firstref="ref24"></nolink> <nolink nlid="nl18" bibid="bib49" firstref="ref25"></nolink> <nolink nlid="nl19" bibid="bib18" firstref="ref26"></nolink> <nolink nlid="nl20" bibid="bib47" firstref="ref28"></nolink> <nolink nlid="nl21" bibid="bib16" firstref="ref29"></nolink> <nolink nlid="nl22" bibid="bib43" firstref="ref30"></nolink> <nolink nlid="nl23" bibid="bib23" firstref="ref31"></nolink> <nolink nlid="nl24" bibid="bib19" firstref="ref32"></nolink> <nolink nlid="nl25" bibid="bib40" firstref="ref33"></nolink> <nolink nlid="nl26" bibid="bib15" firstref="ref34"></nolink> <nolink nlid="nl27" bibid="bib50" firstref="ref35"></nolink> <nolink nlid="nl28" bibid="bib32" firstref="ref37"></nolink> <nolink nlid="nl29" bibid="bib33" firstref="ref38"></nolink> <nolink nlid="nl30" bibid="bib37" firstref="ref39"></nolink> <nolink nlid="nl31" bibid="bib42" firstref="ref40"></nolink> <nolink nlid="nl32" bibid="bib90" firstref="ref41"></nolink> <nolink nlid="nl33" bibid="bib45" firstref="ref42"></nolink> <nolink nlid="nl34" bibid="bib34" firstref="ref43"></nolink> <nolink nlid="nl35" bibid="bib30" firstref="ref44"></nolink> <nolink nlid="nl36" bibid="bib24" firstref="ref45"></nolink> <nolink nlid="nl37" bibid="bib17" firstref="ref46"></nolink> <nolink nlid="nl38" bibid="bib21" firstref="ref47"></nolink> <nolink nlid="nl39" bibid="bib22" firstref="ref48"></nolink> <nolink nlid="nl40" bibid="bib31" firstref="ref49"></nolink> <nolink nlid="nl41" bibid="bib36" firstref="ref51"></nolink> <nolink nlid="nl42" bibid="bib20" firstref="ref52"></nolink> CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=13880209&ISBN=&volume=55&issue=1&date=20170101&spage=906&pages=906-911&title=Pharmaceutical Biology&atitle=Bioactive%20compounds%20from%20Hypericum%20humifusum%20and%20Hypericum%20perfoliatum%3A%20inhibition%20potential%20of%20polyphenols%20with%20acetylcholinesterase%20and%20key%20enzymes%20linked%20to%20type-2%20diabetes&aulast=Afef%20B%C3%A9jaoui&id=DOI:10.1080/13880209.2016.1270973 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/6b16f7fb13a94bfdbd4017e6fc4825cb Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.6b16f7fb13a94bfdbd4017e6fc4825cb RelevancyScore: 896 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 896.106628417969 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Afef+Béjaoui%22">Afef Béjaoui</searchLink><br /><searchLink fieldCode="AR" term="%22Issam+Ben+Salem%22">Issam Ben Salem</searchLink><br /><searchLink fieldCode="AR" term="%22Nesrine+Rokbeni%22">Nesrine Rokbeni</searchLink><br /><searchLink fieldCode="AR" term="%22Yassine+M%27rabet%22">Yassine M’rabet</searchLink><br /><searchLink fieldCode="AR" term="%22Mohamed+Boussaid%22">Mohamed Boussaid</searchLink><br /><searchLink fieldCode="AR" term="%22Abdennacer+Boulila%22">Abdennacer Boulila</searchLink> – Name: TitleSource Label: Source Group: Src Data: Pharmaceutical Biology, Vol 55, Iss 1, Pp 906-911 (2017) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Taylor & Francis Group, 2017. – Name: DatePubCY Label: Publication Year Group: Date Data: 2017 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Therapeutics. Pharmacology – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22hypericum+species%22">hypericum species</searchLink><br /><searchLink fieldCode="DE" term="%22hypericin%22">hypericin</searchLink><br /><searchLink fieldCode="DE" term="%22hyperforin%22">hyperforin</searchLink><br /><searchLink fieldCode="DE" term="%22antioxidant%22">antioxidant</searchLink><br /><searchLink fieldCode="DE" term="%22enzyme+inhibitory%22">enzyme inhibitory</searchLink><br /><searchLink fieldCode="DE" term="%22antimicrobial%22">antimicrobial</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%2E+Pharmacology%22">Therapeutics. Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22RM1-950%22">RM1-950</searchLink> – Name: Abstract Label: Description Group: Ab Data: Context: Natural products are reported to have a wide spectrum of pharmacological properties such as antimicrobial, anti-inflammatory and anti-cholinesterase. The genus Hypericum (Hypericaceae) is a source of a variety of molecules with different biological activities, notably hypericin and various phenolics. Objectives: The goals of the present work were the determination of total phenolic and flavonoid content, hypericin and hyperforin concentration as well as the evaluation of biological of Hypericum humifusum L. (Hhu) and Hypericum perfoliatum L. (Hper). Materials and methods: The various extracts of aerial parts were powdered, and then extracted with methanol. Antibacterial activity was performed according to minimum inhibitory concentration (MIC) and minimum bactericidal (MBC) methods against four Gram-positive bacteria, four Gram-negative bacteria and yeast. Results: The results revealed that H. humifusum, bear the highest total phenolic and flavonoid content (48–113 mg GAE/g and 8–41 mg RE/g, respectively) as well as hypericin (60–90 mg/g) and hyperforin (8–30 mg/g) concentration. Both species showed significant antioxidant activity as revealed by DPPH, FRAP, ABTS, and metal chelating assays. H. humifusum exhibited a strong acetylcholinesterase (3.86–4.57 mg GALAEs/g), α-glucosidase (0.73–2.55 mmol ACEs/g) and α-amylase (3–8 mmol ACEs/g) inhibitory activity. The extract of H. humifusum exhibited strong antibacterial activity mainly against Staphylococcus epidermidis, Staphylococus aureus, and Enterococcus faecium (MIC values ranging from 200 to 250 μg/mL). The highest antifungal activity was showed for H. perfoliatum extract (MIC value = 250 μg/mL). Conclusion: The data suggest that H. humifusum could be used as valuable new natural agents with functional properties for pharmacology industries. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1388-0209<br />1744-5116<br />13880209 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://doaj.org/toc/1388-0209; https://doaj.org/toc/1744-5116 – Name: DOI Label: DOI Group: ID Data: 10.1080/13880209.2016.1270973 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/6b16f7fb13a94bfdbd4017e6fc4825cb" linkWindow="_blank">https://doaj.org/article/6b16f7fb13a94bfdbd4017e6fc4825cb</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.6b16f7fb13a94bfdbd4017e6fc4825cb |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6b16f7fb13a94bfdbd4017e6fc4825cb |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13880209.2016.1270973 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 906 Subjects: – SubjectFull: hypericum species Type: general – SubjectFull: hypericin Type: general – SubjectFull: hyperforin Type: general – SubjectFull: antioxidant Type: general – SubjectFull: enzyme inhibitory Type: general – SubjectFull: antimicrobial Type: general – SubjectFull: Therapeutics. Pharmacology Type: general – SubjectFull: RM1-950 Type: general Titles: – TitleFull: Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Afef Béjaoui – PersonEntity: Name: NameFull: Issam Ben Salem – PersonEntity: Name: NameFull: Nesrine Rokbeni – PersonEntity: Name: NameFull: Yassine M’rabet – PersonEntity: Name: NameFull: Mohamed Boussaid – PersonEntity: Name: NameFull: Abdennacer Boulila IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 13880209 – Type: issn-print Value: 17445116 Numbering: – Type: volume Value: 55 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceutical Biology Type: main |
ResultId | 1 |